HIV ACQUISITION

Information

• Research Project
• 2312796

• ApplicationId

  2312796

• Core Project Number

  N01HB057128

• Full Project Number

  N01HB057128-000

• Serial Number

  57128

• FOA Number

• Sub Project Id

• Project Start Date

  3/1/1995 - 29 years ago

• Project End Date

  -

• Program Officer Name

• Budget Start Date

  3/1/1995 - 29 years ago

• Budget End Date

  2/29/1996 - 28 years ago

• Fiscal Year

  1995

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• NABI

The objective of this project is the manufacture of 12,706 grams of hyperimmune, anti-HIV-specific intravenous immunoglobulin (HIVIG) for the conduct of a clinical trial which will evaluate the safety and efficacy of this product in interrupting vertical transmission of HIV from infected women to their offspring. Some of this HIVIG (2,250 grams) will be used to conduct a small clinical study to evaluate the safety, tolerance and dosage of this product in slowing progression of disease in HIV-infected children.

IC Name

• Activity

  N01

• Administering IC

  HB

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  839

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

• Study Section Name

• Organization Name

  NORTH AMERICAN BIOLOGICALS, INC.

• Organization Department

• Organization DUNS

• Organization City

  MIAMI

• Organization State

  FL

• Organization Country

  UNITED STATES

• Organization Zip Code

  33169

• Organization District

  UNITED STATES